The norepinephrine transporter gene is associated with the retardation symptoms of major depressive disorder in the Han Chinese population
The norepinephrine transporter plays an important role in the pathophysiology and pharmacological treatment of major depressive disorder. Consequently, the norepinephrine transporter gene is an attractive candidate in major depressive disorder research. In the present study, we evaluated the depress...
Saved in:
Published in | Neural regeneration research Vol. 7; no. 25; pp. 1985 - 1991 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
India
Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China%Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
05.09.2012
Nursing College of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China Medknow Publications & Media Pvt Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 1673-5374 1876-7958 |
DOI | 10.3969/j.issn.1673-5374.2012.25.010 |
Cover
Loading…
Summary: | The norepinephrine transporter plays an important role in the pathophysiology and pharmacological treatment of major depressive disorder. Consequently, the norepinephrine transporter gene is an attractive candidate in major depressive disorder research. In the present study, we evaluated the depression symptoms of subjects with major depressive disorder, who were all from the North of China and of Hart Chinese origin, using the Hamilton Depression Scale. We examined the relationship between two single nucleotide polymorphisms in the norepinephrine transporter, rs2242446 and rs5569, and the retardation symptoms of major depressive disorder using quantitative trait testing with the UNPHASED program, rs5569 was associated with depressed mood, and the GG genotype may be a risk factor for this; rs2242446 was associated with work and interest, and the TT genotype may be a risk factor for loss of interest. Our findings suggest that rs2242446 and rs5569 in the norepinephrine transporter gene are associated with the retardation symptoms of depression in the Hart Chinese population. |
---|---|
Bibliography: | Norepinephrine transporter; major depressive disorder; quantitative trait locus; gene polymorphism;retardation symptoms; Hamilton Depression Scale; endophenotype; single nucleotidepolymorphism; pathogenesis The norepinephrine transporter plays an important role in the pathophysiology and pharmacological treatment of major depressive disorder. Consequently, the norepinephrine transporter gene is an attractive candidate in major depressive disorder research. In the present study, we evaluated the depression symptoms of subjects with major depressive disorder, who were all from the North of China and of Hart Chinese origin, using the Hamilton Depression Scale. We examined the relationship between two single nucleotide polymorphisms in the norepinephrine transporter, rs2242446 and rs5569, and the retardation symptoms of major depressive disorder using quantitative trait testing with the UNPHASED program, rs5569 was associated with depressed mood, and the GG genotype may be a risk factor for this; rs2242446 was associated with work and interest, and the TT genotype may be a risk factor for loss of interest. Our findings suggest that rs2242446 and rs5569 in the norepinephrine transporter gene are associated with the retardation symptoms of depression in the Hart Chinese population. 11-5422/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Xinrong Li, Master, Attending physician, Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China Author contributions: Xinrong Li wrote the manuscript and conducted the biological experiments. Ning Sun was responsible for data analysis and conducted the biological experiments. Yong Xu, Yanfang Wang, Juyi Peng, and Jinxiu Luo collected the participants. Suping Li and Qiaorong Du assessed the patients’ symptoms. Kerang Zhang designed the study and revised the manuscript. Xinrong Li and Ning Sun contributed equally to this work. |
ISSN: | 1673-5374 1876-7958 |
DOI: | 10.3969/j.issn.1673-5374.2012.25.010 |